LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 105 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 34,935,485 | $41,223,872 | 3.66% |
| Raffles Associates | 1,587,739 | $1,873,532 | 2.48% |
| Defender Capital, LLC. | 5,184,510 | $6,117,722 | 2.22% |
| Prescott General Partners LLC | 1,851,851 | $2,185,184 | 0.14% |
| DCF Advisers, LLC | 82,751 | $97,646 | 0.05% |
| Beirne Wealth Consulting Services, LLC | 45,000 | $63,450 | 0.05% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 781,766 | $922,484 | 0.02% |
| Fort Sheridan Advisors LLC | 83,931 | $99,039 | 0.02% |
| MAI Capital Management | 954,688 | $1,126,532 | 0.02% |
| Piscataqua Savings Bank | 12,499 | $14,623 | 0.01% |
| Straight Path Wealth Management | 16,200 | $19,116 | 0.01% |
| ELCO Management Co., LLC | 12,000 | $14,160 | 0.01% |
| Allegheny Financial Group LTD | 20,000 | $23,600 | 0.01% |
| Long Focus Capital Management, LLC | 215,000 | $253,700 | 0.01% |
| TRUST CO OF TOLEDO NA /OH/ | 33,795 | $39,878 | 0.01% |
| Laurion Capital Management LP | 1,136,471 | $1,341,036 | 0.01% |
| Founders Capital Management | 8,000 | $9,440 | 0.01% |
| SkyOak Wealth, LLC | 15,000 | $17,700 | 0.01% |
| Elgethun Capital Management | 15,000 | $18,000 | 0.01% |
| UNITED BANK | 29,800 | $35,164 | 0.01% |
External links
This page lists LINEAGE CELL THERAPEUTICS IN's shareholders in Q3 2023. To view LINEAGE CELL THERAPEUTICS IN's shareholder history, click here.